<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Neuroanat</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Neuroanat</journal-id>
<journal-id journal-id-type="publisher-id">Front. Neuroanat.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Neuroanatomy</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5129</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29497366</article-id>
<article-id pub-id-type="pmc">5818405</article-id>
<article-id pub-id-type="doi">10.3389/fnana.2018.00011</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Confocal Synaptology: Synaptic Rearrangements in Neurodegenerative Disorders and upon Nervous System Injury</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Vulovic</surname>
<given-names>Maja</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/509391/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Divac</surname>
<given-names>Nevena</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/284254/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jakovcevski</surname>
<given-names>Igor</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/5026/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Anatomy, Faculty of Medical Sciences, University of Kragujevac</institution>, <addr-line>Kragujevac</addr-line>, <country>Serbia</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade</institution>, <addr-line>Belgrade</addr-line>, <country>Serbia</country></aff>
<aff id="aff3"><sup>3</sup><institution>Institute for Molecular and Behavioral Neuroscience, University Hospital Cologne, Center for Molecular Medicine Cologne</institution>, <addr-line>Cologne</addr-line>, <country>Germany</country></aff>
<aff id="aff4"><sup>4</sup><institution>Experimental Neurophysiology, German Center for Neurodegenerative Diseases</institution>, <addr-line>Bonn</addr-line>, <country>Germany</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Javier DeFelipe, Cajal Institute (CSIC), Spain</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: James C. Vickers, University of Tasmania, Australia; Matthew J. Broadhead, University of St Andrews, United Kingdom</p>
</fn>
<corresp id="fn001">*Correspondence: Igor Jakovcevski <email xlink:type="simple">igor.jakovcevski@dzne.de</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>12</volume>
<elocation-id>11</elocation-id>
<history>
<date date-type="received">
<day>15</day>
<month>11</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>01</day>
<month>2</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Vulovic, Divac and Jakovcevski.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Vulovic, Divac and Jakovcevski</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>The nervous system is a notable exception to the rule that the cell is the structural and functional unit of tissue systems and organs. The functional unit of the nervous system is the synapse, the contact between two nerve cells. As such, synapses are the foci of investigations of nervous system organization and function, as well as a potential readout for the progression of various disorders of the nervous system. In the past decade the development of antibodies specific to presynaptic terminals has enabled us to assess, at the optical, laser scanning microscopy level, these subcellular structures, and has provided a simple method for the quantification of various synapses. Indeed, excitatory (glutamatergic) and inhibitory synapses can be visualized using antibodies against the respective vesicular transporters, and choline-acetyl transferase (ChAT) immunoreactivity identifies cholinergic synapses throughout the central nervous system. Here we review the results of several studies in which these methods were used to estimate synaptic numbers as the structural equivalent of functional outcome measures in spinal cord and femoral nerve injuries, as well as in genetic mouse models of neurodegeneration, including Alzheimer’s disease (AD). The results implicate disease- and brain region-specific changes in specific types of synapses, which correlate well with the degree of functional deficit caused by the disease process. Additionally, results are reproducible between various studies and experimental paradigms, supporting the reliability of the method. To conclude, this quantitative approach enables fast and reliable estimation of the degree of the progression of neurodegenerative changes and can be used as a parameter of recovery in experimental models.</p>
</abstract>
<kwd-group>
<kwd>Alzheimer’s disease</kwd>
<kwd>cholinergic synapses</kwd>
<kwd>femoral nerve</kwd>
<kwd>hippocampus</kwd>
<kwd>spinal cord injury</kwd>
<kwd>vesicular glutamate transporters</kwd>
<kwd>vesicular inhibitory transmitter transporters</kwd>
</kwd-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="74"></ref-count>
<page-count count="9"></page-count>
<word-count count="7475"></word-count>
</counts>
</article-meta>
</front>
<body>
<p>Cells are the basic structural, functional and biological units of tissues and organs. The nervous system, however, has one peculiarity—rather than a single cell, for the proper functioning of the nervous system a connection between two cells, the synapse, is essential. According to the neuron doctrine, chemical synapses are basic building blocks of neural circuitry (Bullock et al., <xref ref-type="bibr" rid="B12">2005</xref>). Typical synapses include a presynaptic axonal terminal, synaptic cleft and a postsynaptic, most commonly dendritic, part of the synapse. The action potential travels through the axon and at its terminal causes voltage-gated calcium channels to open. An influx of calcium causes synaptic vesicles to merge with the membrane and release neurotransmitter, which binds to its receptor—a ligand gated ion channel—and causes changes in the postsynaptic potential (Südhof and Malenka, <xref ref-type="bibr" rid="B66">2008</xref>). Excitatory and inhibitory postsynaptic potentials are integrated, eventually reaching the threshold, which leads to firing of another action potential. This is a simplified, but for our purpose sufficient description of how the nervous system works. Notably, the synapse plays a central role in the transmission of information from one neuron to another (Bullock et al., <xref ref-type="bibr" rid="B12">2005</xref>).</p>
<p>As the size of a single synapse is well below 1 μm, for the most of the previous century research on synapses was based on electron microscopy. Using electron microscopy, the two classical types of synapses were described—an asymmetric, glutamatergic, excitatory synapse where the postsynaptic density appears thicker than the presynaptic one and the symmetric, inhibitory synapse (Peters, <xref ref-type="bibr" rid="B55">2002</xref>). At the turn of the century, several antibodies for different presynaptic markers were developed, which could specifically identify various types of synapses (Takamori et al., <xref ref-type="bibr" rid="B67">2000</xref>; Fujiyama et al., <xref ref-type="bibr" rid="B26">2001</xref>). Together with the improvement of the resolution of confocal laser scanning microscopes, these markers, used for indirect immunofluorescence staining, became instrumental in gaining insight into the functional significance of synaptic remodeling in various nervous system disease models. Here we aim to present several examples where this simple technique was used in conjunction with functional assessments, to correlate synaptic and functional outcome, introducing confocal synaptology as a functionally relevant readout for animal models of neurological disorders. As our examples are focused on the labeling with antibodies against presynaptic markers, we will only briefly touch upon other labeling possibilities, as well as other technical issues of light microscopy in this context.</p>
<sec id="s1">
<title>Technical Clarifications</title>
<p>Antibodies will visualize synapses best when they have higher affinity for terminals rather than axons. To that end, antibodies for vesicular transporters for inhibitory (VGAT) and excitatory (VGLUT) transmitters are ideal, as they specifically label presynaptic terminals (Figures <xref ref-type="fig" rid="F1">1</xref>–<xref ref-type="fig" rid="F3">3</xref>). As the inhibitory (mainly gamma-aminobutyric acid—GABA—positive) synapses target mostly cell bodies and proximal dendrites of neurons, we count the number of VGAT-expressing puncta surrounding the neuron cell bodies and normalize it to the cell perimeter (Figure <xref ref-type="fig" rid="F1">1</xref>; original data published in Schmalbach et al., <xref ref-type="bibr" rid="B64">2015</xref>). This method was used on the pyramidal cells of the cortical layer 5 (Irintchev et al., <xref ref-type="bibr" rid="B37">2005</xref>), hippocampal principal neurons (pyramidal neurons in the Amon’s horn—CA, and granule cells of the dentate gyrus—DG; e.g., Nikonenko et al., <xref ref-type="bibr" rid="B53">2006</xref>; Radonjić et al., <xref ref-type="bibr" rid="B58">2013</xref>), cerebellum Purkinje neurons (Jakovcevski et al., <xref ref-type="bibr" rid="B40">2009</xref>), and spinal cord motoneurons (Apostolova et al., <xref ref-type="bibr" rid="B4">2006</xref>). To standardize the perimeter length stacks of images of 0.5 or 1 μm thickness are obtained on a confocal microscope using 63× or 100× oil immersion objectives and at a high digital resolution (e.g., 1024 × 1024 or 2048 × 2048 pixels would suffice). One image per cell at the level of the largest cell body cross-sectional area is used for measurement (Figure <xref ref-type="fig" rid="F1">1</xref>). The number of individually discernible structures is counted and then normalized to the perimeter of the cell measured (Figure <xref ref-type="fig" rid="F2">2A</xref>). A similar method is applied for the estimation of the cholinergic, choline-acetyl transferase (ChAT)-positive, terminals around spinal cord motoneuron cell bodies (Davidoff and Irintchev, <xref ref-type="bibr" rid="B21">1986</xref>; Apostolova et al., <xref ref-type="bibr" rid="B4">2006</xref>). Although ChAT antibody stains motoneuron cell bodies and axons, immunoreactivity is strongest in the presynaptic terminals (Figure <xref ref-type="fig" rid="F4">4</xref>). Thus, the number of cholinergic synapses can also be normalized to the cell perimeter (length). Alternatively, the antibody for vesicular acetylcholine transporter can be used, having the similar staining pattern (Schäfer et al., <xref ref-type="bibr" rid="B63">1998</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Inhibitory synapses in the dentate gyrus (DG) of the hippocampus. Immunofluorescent co-staining for VGAT (red) and parvalbumin (PV; green) in the wild-type mouse hippocampus. A serial stack of images of 1 μm thickness through the DG obtained on a confocal microscope. Asterisks label several examples of the cells used for the analysis. Scale bar: 20 μm. This figure contains images from the study originally published in Schmalbach et al. (<xref ref-type="bibr" rid="B64">2015</xref>).</p>
</caption>
<graphic xlink:href="fnana-12-00011-g0001"></graphic>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p>Inhibitory synapses in the hippocampus of Alzheimer’s disease (AD) model mice. <bold>(A)</bold> Immunofluorescent staining for VGAT (red) of a single pyramidal neuron in the CA1 of a wild-type mouse. Arrows point to single terminals. <bold>(B)</bold> Linear density (number of terminals per unit length) of inhibitory (VGAT+) synapses, further subdivided into PV+ and PV− terminals in the wild-type (C57BL/6J) and AD model (APPPS1) hippocampi. Data are presented as mean + standard error of the mean, asterisks indicate <italic>p</italic> &lt; 0.05, <italic>t</italic>-test; <italic>n</italic> = 5 mice/group. Scale bar: 10 μm. This figure contains images and data from the study originally published in Djogo et al. (<xref ref-type="bibr" rid="B23">2013</xref>).</p>
</caption>
<graphic xlink:href="fnana-12-00011-g0002"></graphic>
</fig>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<p>Excitatory synapses in the cerebellum. <bold>(A)</bold> Immunofluorescent co-staining for VGLUT1 (green) and PV (red) in the wild-type mouse cerebellum. Shown are Purkinje cell layer (bottom part of both images) and the molecular layer (upper part of images), where these synapses are located. <bold>(B)</bold> Immunofluorescent co-staining for VGLUT2 (red) and calbindin (green) in the wild-type mouse cerebellum. <bold>(C,D)</bold> Single images from A <bold>(C)</bold>, B <bold>(D)</bold> showing only VGLUT1 and VGLUT2 staining, respectively. Note diffuse staining pattern in the molecular layer with VGLUT1, leaving only putative interneurons unstained. On the contrary, VGLUT2 staining is more discrete, and confined to the main branches of Purkinje cell dendrites. Scale bars: 20 μm. This figure contains images from the study originally published in Jakovcevski et al. (<xref ref-type="bibr" rid="B40">2009</xref>).</p>
</caption>
<graphic xlink:href="fnana-12-00011-g0003"></graphic>
</fig>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<p>Cholinergic synapses in the spinal cord. <bold>(A)</bold> Immunofluorescent staining for choline-acetyl transferase (ChAT; red) of the non-injured wild-type mouse spinal cord transverse section in the lumbar region. <bold>(B)</bold> Higher magnification of motoneurons in the ventral horn, red dots around cell bodies represent cholinergic C-terminals. <bold>(C)</bold> Cholinergic interneurons around central canal, a source of C-terminals on motoneurons. <bold>(D)</bold> Linear density (number of terminals per unit length) of cholinergic (ChAT+) synapses in wild-type (C57BL/6J) of non-injured and injured mice above and below the lesion site (LS). Data are presented as mean + standard error of the mean, asterisks indicate <italic>p</italic> &lt; 0.05, <italic>t</italic>-test; <italic>n</italic> = 6 mice/group. Scale bars: 100 μm <bold>(A)</bold>, 20 μm <bold>(B,C)</bold>. This figure contains data and images from the study originally published in Jakovcevski et al. (<xref ref-type="bibr" rid="B41">2007</xref>, <xref ref-type="bibr" rid="B38">2013a</xref>).</p>
</caption>
<graphic xlink:href="fnana-12-00011-g0004"></graphic>
</fig>
<p>With regard to the far more numerous glutamatergic, excitatory synaptic terminals the situation is not as simple. Whereas both main inhibitory transmitters, GABA and glycin are packed in VGAT-expressing vesicles, there are at least three types of vesicular transporters for glutamate, VGLUT1-3 (Liguz-Lecznar and Skangiel-Kramska, <xref ref-type="bibr" rid="B47">2007</xref>). These three types are mostly complementary, with little overlap, VGLUT1 being the main transporter in the cerebral cortex and hippocampus, while VGLUT2 is expressed in the granular layer of the DG, thalamus, hypothalamus and brainstem (Fujiyama et al., <xref ref-type="bibr" rid="B26">2001</xref>; Fremeau et al., <xref ref-type="bibr" rid="B25">2004</xref>). In the cerebellum, parallel fibers express VGLUT1, whereas climbing fibers express VGLUT2 (Hisano et al., <xref ref-type="bibr" rid="B32">2002</xref>). VGLUT3 distribution is restricted to particular populations of neurons, furthermore it is expressed in a subpopulation of inhibitory synapses in the hippocampus and neocortex, as well as cholinergic and serotonergic neurons. This lead to an idea that glutamate could be co-released with another transmitter and modulating its effects (Liguz-Lecznar and Skangiel-Kramska, <xref ref-type="bibr" rid="B47">2007</xref>). Therefore, VGLUT3 cannot be used as a reliable marker for glutamatergic transmission. To estimate glutamatergic transmission using VGLUT1 or VGLUT2 digital images obtained on a confocal microscope are processed with ImageJ software (NIH, Bethesda, MD, USA). The gray value is adjusted using threshold to convert the images to gray scale for optimal color intensity with ImageJ. Criteria for identification of synaptic terminals may vary depending on the brain region with respect to object size and circularity. Density is calculated as the number of VGLUT1<sup>+</sup> synaptic terminals per unit area. One should emphasize that the expression “linear density” (number of terminals per unit length) and “density” (number of terminals per unit area) should not be confused with the “synaptic density” (as in pre- and post-synaptic densities) commonly used in electron microscopy.</p>
<p>In addition to the possibility to combine the presynaptic terminal markers with cell-type specific markers, e.g., VGAT with parvalbumin (PV), to focus on a specific type of synaptic input (see below), it is also possible to use both presynaptic and postsynaptic markers, to ensure the more precise definition of the synapse. This analysis is more laborious and demanding, but are more likely to quantify true synapses, especially when combined with super-resolution microscopy and 3D reconstruction (Janz et al., <xref ref-type="bibr" rid="B100">2017</xref>). Postsynaptic markers such as post-synaptic density protein 95 (PSD-95), localized exclusively to excitatory synapses (Hunt et al., <xref ref-type="bibr" rid="B34">1996</xref>) and gephyrin, localized to inhibitory synapses (Sassoè-Pognetto and Fritschy, <xref ref-type="bibr" rid="B62">2000</xref>) are a good choice to be combined with VGLUT1 and VGAT, respectively. However, the double-labeling is often burdened with unequal penetration of the two antibodies, which makes analysis more difficult (Janz et al., <xref ref-type="bibr" rid="B100">2017</xref>). Additionally, about 20% of dendritic spines lack PSD-95, although it is not clear if these spines are functionally significant, which further complicates the interpretation of results (Berry and Nedivi, <xref ref-type="bibr" rid="B7">2017</xref>).</p>
<p>Another way to address the specificity of synaptic labeling would be by using genetic mouse models or viruses encoding fluorescent proteins expressed by pre- or postsynaptic terminals. They have clear advantages over the classical immunostaining, but breeding the animals is time consuming, and viral injections are invasive and expression/transduction is usually incomplete, so their utilization is very much dependent on the experimental settings.</p>
<p>Although the power of electron microscopy is unquestionably higher in revealing the ultrastructure of neural tissue, recent advances of fluorescence light microscopy are directed to overcome the diffraction limit of the visible light (the resolution limit of 200 nm), as the main obstacle to resolve morphological details at the subcellular and even molecular level (Dani and Huang, <xref ref-type="bibr" rid="B20">2010</xref>). Combined with the inherent advantages of fluorescence microscopy, including possibility to visualize protein colocalization, cell-specific protein marker expression, and various forms of genetic or dye-based labeling, even the possibility to work with cell or tissue cultures, the new super-resolution techniques which achieve resolutions up to 20 nm are opening new possibilities for Huang et al. (<xref ref-type="bibr" rid="B33">2008</xref>).</p>
</sec>
<sec id="s2">
<title>The Role of the Close Homolog of L1 in the Development and Aging of Inhibitory Synapses in the Hippocampus</title>
<p>One of the first studies to show that estimation of the synaptic coverage by confocal microscopy corresponds well with the “gold standard” electron microscopic method was the investigation of the hippocampus in juvenile close homolog of L1 (CHL1)—deficient mice (Nikonenko et al., <xref ref-type="bibr" rid="B53">2006</xref>). Similar to L1, its homolog CHL1 is an immunoglobulin superfamily adhesion molecule implicated in axonal growth and pathfinding, neuronal migration and synapse formation (Demyanenko et al., <xref ref-type="bibr" rid="B22">2004</xref>; Wright et al., <xref ref-type="bibr" rid="B70">2007</xref>; Katic et al., <xref ref-type="bibr" rid="B42">2014</xref>). Among others, it has been associated with schizophrenia and autism spectrum disorders in humans (Angeloni et al., <xref ref-type="bibr" rid="B3">1999</xref>; Chen et al., <xref ref-type="bibr" rid="B17">2005</xref>). Mice constitutively lacking CHL1 (CHL1−/−) show behavioral deficits congruent with psychiatric disorders (Irintchev et al., <xref ref-type="bibr" rid="B35">2004</xref>; Kolata et al., <xref ref-type="bibr" rid="B44">2008</xref>). A role of CHL1 in the establishment of the inhibitory circuitry has been demonstrated in the CA1 field of the hippocampus. Juvenile (1-month-old) CHL1−/− mice develop increased numbers of PV-expressing (PV+) interneurons in the CA1, which account for the most of the fast-spiking interneurons in this area (Gulyás et al., <xref ref-type="bibr" rid="B27">1999</xref>). In this study the estimation of the symmetric, inhibitory perisomatic synapses by electron microscopy was performed in parallel with the counting of VGAT+ inhibitory synapses abound the cell bodies of CA1 pyramidal neurons. Both methods showed increased numbers of perisomatic synapses in CHL1−/− compared with wild-type animals, the latter being capable of distinguishing between PV+ and PV− terminals, which were both affected to the approximately same degree (Nikonenko et al., <xref ref-type="bibr" rid="B53">2006</xref>). To test for the physiological relevance of this apparent increase in the inhibition, authors measured inhibitory postsynaptic currents (IPSCs) in the presence of a glutamate receptor antagonist. The mean amplitude of IPSCs was increased in CHL1−/− mice compared with wild-type controls. As GABAergic transmission was apparently increased in CHL1−/− mice, further hypothesis was that this abnormality might lead to a reduction of long-term potentiation (LTP), an electrophysiological correlate of memory formation (Bliss and Lomo, <xref ref-type="bibr" rid="B9">1973</xref>; Nicoll, <xref ref-type="bibr" rid="B52">2017</xref>). To verify this hypothesis, authors stimulated axons of CA3 neurons and recorded field excitatory postsynaptic potentials (fEPSPs) in the stratum radiatum of the CA1 region. LTPs evoked by five trains of theta-burst stimulation were significantly reduced in CHL1−/− as compared with wild-type mice. To show that the increased inhibition is the cause of this deficit, the authors blocked the GABA<sub>A</sub> receptors with picrotoxin, which lead to similar LTPs in both genotypes (Nikonenko et al., <xref ref-type="bibr" rid="B53">2006</xref>). Thus, the increased inhibition causes the reduction of LTP, i.e., functional deficit in juvenile CHL1−/− mice. Interestingly, the follow-up study which analyzed the senescence of CHL1−/− mice, has shown that the number of PV+ interneurons normalizes in adult, 2-month-old mice and at later ages, 6 and 12 months, they are reduced in number compared to wild-type. Congruently, LTP normalizes at 2 months, but later, at 9 months it decreases again, relative to the wild-type values (Schmalbach et al., <xref ref-type="bibr" rid="B64">2015</xref>). This example shows that the alteration in specific synapses can be correlated with functional deficits, and that this correlation can progress during animal lifespan. This may be relevant for the investigation of complex human-specific diseases, such as schizophrenia, as, besides the obvious connection with the loss of PV+ interneurons, some other neurological and immunological features in CHL1−/− mice resemble the pathology seen in schizophrenic patients (Schmalbach et al., <xref ref-type="bibr" rid="B64">2015</xref>).</p>
</sec>
<sec id="s3">
<title>Alzheimer’S Disease: The Loss of Hippocampal Inhibitory Synapses</title>
<p>Alzheimer’s disease (AD) is commonly diagnosed disorder in the elderly characterized by degenerative changes in neurons, amyloid plaques, neurofibrillary tangles, and progressive diminishing of working memory and intellectual capacities (Querfurth and LaFerla, <xref ref-type="bibr" rid="B56">2010</xref>). The most commonly used mouse model of this disorder is generated by overexpressing human mutated amyloid precursor protein, so-called “Swedish mutation” (Radde et al., <xref ref-type="bibr" rid="B57">2006</xref>). These mice display cerebral amyloidosis, gliosis and later in life a working memory deficit. As there is no therapy for cerebral amyloidosis, and for AD, we tried an experimental treatment with gene transfer, as a proof-of concept study. To that end we used neural adhesion molecule L1, shown in various experimental neural disease paradigms to be neuroprotective and gliosis limiting agent (Chen et al., <xref ref-type="bibr" rid="B16">2007</xref>; Cui et al., <xref ref-type="bibr" rid="B18">2010</xref>; Xu et al., <xref ref-type="bibr" rid="B72">2011</xref>; Lee et al., <xref ref-type="bibr" rid="B45">2012</xref>), and overexpressed it in the hippocampus of the transgenic mouse model for AD (Djogo et al., <xref ref-type="bibr" rid="B23">2013</xref>). Using adeno-associated virus serotype 5, we achieved a robust L1 expression in neurons and in astrocytes in the hippocampus. The beneficial effects seen in L1 treated group of mice included a decrease in amyloid plaque load and in astrogliosis, and, from the functional point most significantly, ameliorated loss of inhibitory synapses on the hippocampal pyramidal neurons. At 8 months of age, when the number of neurons is still normal in the hippocampus of these mice (Radde et al., <xref ref-type="bibr" rid="B57">2006</xref>), the perisomatic VGAT-positive inhibitory synapses around principal neurons were reduced in the CA1 and CA3 fields, but not in the DG (Figure <xref ref-type="fig" rid="F2">2B</xref>). This was true for both PV-positive and PV-negative inhibitory synapses, suggesting decreased overall local circuitry inhibition (Figure <xref ref-type="fig" rid="F2">2</xref>). L1 transduction reduced synaptic loss in affected areas, although it could not completely protect the synapses (Djogo et al., <xref ref-type="bibr" rid="B23">2013</xref>). This example shows how synaptic loss can be an early predictor of disease development, and a functionally relevant structural parameter to estimate treatment efficacy, as synaptic loss is a major correlate of cognitive impairment in human AD patients (Terry et al., <xref ref-type="bibr" rid="B68">1991</xref>; Arendt, <xref ref-type="bibr" rid="B5">2009</xref>).</p>
</sec>
<sec id="s4">
<title>Cerebellum Development</title>
<p>The cerebellar cortex is particularly interesting, as it has one of the best described circuitries. Purkinje cells are its principal neurons contacted by the afferent climbing fibers originating from the brainstem. Granule cells constitute the major population of excitatory interneurons which project their axons, the parallel fibers, to the Purkinje cell dendrites. The inhibitory stellate and basket interneurons also target their axons onto the dendrites and cell bodies of Purkinje cells. This circuitry has an additional appeal, as the excitatory input is particularly well defined. The integrated sensory information comes from the inferior olives as climbing fibers (VGLUT2-positive), which directly innervate Purkinje cell dendrites. Various other brainstem areas project mossy fibers (VGLUT1-expressing), which innervate granule cells, which in turn project parallel fibers (also VGLUT1-positive) through molecular layer onto Purkinje cell dendrites. The sole output of the cerebellar cortex are Purkinje neuron axons, which are inhibitory, express VGAT and calbindin and synapse on the deep cerebellar nuclei. Interestingly, whereas parallel fibers innervate many (approximately thousand) Purkinje cells, each climbing fiber innervates a single Purkinje neuron (Cajal, <xref ref-type="bibr" rid="B14">1911</xref>; Eccles et al., <xref ref-type="bibr" rid="B24">1966</xref>).</p>
<p>In CHL1−/− mice the cerebellar cortex develops lower numbers of Purkinje and granule neurons, with normal numbers of interneurons, which indicates an increased inhibition/excitation ratio. We, therefore, studied the inhibitory, VGAT-positive terminals on Purkinje cell bodies and dendrites, and discovered that their density was similar to the wild-type. The density of VGLUT1-positive (parallel fibers) terminals in the molecular layer was normal as well. The only difference was in the decreased number of VGLUT2-positive climbing fiber terminals, congruent with the lower number of Purkinje neurons, as the single climbing fiber innervates single Purkinje cell (Figure <xref ref-type="fig" rid="F3">3</xref>). Our next hypothesis was that branching of Purkinje cell dendrites was compensatory increased in CHL1−/− mice, which indeed was the case (Jakovcevski et al., <xref ref-type="bibr" rid="B40">2009</xref>). It is tempting to hypothesize that developmental compensation at the level of Purkinje cell dendrites accounts for the lack of the functional cerebellar phenotype in CHL1−/− mice. This exemplifies how the presynaptic changes could be compensated through the changes on the postsynaptic side so that the overall function is not disturbed. It also emphasizes the importance of studying both the presynaptic terminals and dendritic spines to fully understand the synapses and their functional significance.</p>
</sec>
<sec id="s5">
<title>Spinal Cord Injury</title>
<p>Spinal cord injury is a severe neurological disorder which affects mostly young people and greatly reduces both life expectancy and quality (Ahuja et al., <xref ref-type="bibr" rid="B1">2017</xref>). As there are no reliable therapies, regeneration after injury is a major target of research in neurobiology, ever since Cajal observed and postulated that central nervous system axons do not regenerate (Cajal, <xref ref-type="bibr" rid="B13">1928</xref>). The spinal cord has an extremely intricate circuitry, details of which are still largely unknown, with many types of interneurons, some of which are probably as of today unrecognized (Bikoff et al., <xref ref-type="bibr" rid="B8">2016</xref>). One well-described part of this circuitry are the cholinergic V0 interneurons which form large C-type synapses on alpha motoneurons in spinal cord segments below them (Zagoraiou et al., <xref ref-type="bibr" rid="B73">2009</xref>). Those synapses are currently thought of as the modulators of motoneuron firing (Miles et al., <xref ref-type="bibr" rid="B50">2007</xref>). Importantly, they are clearly visualized with ChAT antibodies which stain motoneuron cell bodies as well, but they stain the terminals particularly strong (Figures <xref ref-type="fig" rid="F4">4A–C</xref>). These cholinergic synapses are reduced in number after spinal cord injury (Apostolova et al., <xref ref-type="bibr" rid="B4">2006</xref>). Interestingly, this reduction is true for the cholinergic synapses on motoneurons below the lesion site (LS), whereas above the LS the number of these synapses after injury is slightly increased (Figure <xref ref-type="fig" rid="F4">4D</xref>; Jakovcevski et al., <xref ref-type="bibr" rid="B38">2013a</xref>). This underlines the complexity of synaptic re-arrangements after spinal cord injury.</p>
<p>It has been shown that upon spinal cord injury CHL1−/− mice recover locomotor function better than their wild-type littermates, due to the homophilic CHL1-CHL1 signaling between astrocytes and neurons, which interferes with axonal regeneration (Jakovcevski et al., <xref ref-type="bibr" rid="B41">2007</xref>). In this mouse model we have shown that the reduction of cholinergic terminals 6 weeks after injury positively correlates with the severity of motor deficit on an individual animal basis. This was done using linear regression and comparing the density of cholinergic synapses with the “gold standard” BMS score (Basso et al., <xref ref-type="bibr" rid="B6">2006</xref>), as well as the single-frame motion analysis locomotor scoring (Apostolova et al., <xref ref-type="bibr" rid="B4">2006</xref>). Several other studies in the mouse model of spinal cord injury have consistently reported that the higher number of cholinergic synapses around motoneurons corresponds to the improved locomotor outcome (Cui et al., <xref ref-type="bibr" rid="B19">2011</xref>; Xu et al., <xref ref-type="bibr" rid="B72">2011</xref>; Lee et al., <xref ref-type="bibr" rid="B45">2012</xref>; Wu et al., <xref ref-type="bibr" rid="B71">2012</xref>; Papastefanaki et al., <xref ref-type="bibr" rid="B54">2015</xref>; Rost et al., <xref ref-type="bibr" rid="B60">2016</xref>; Saini et al., <xref ref-type="bibr" rid="B61">2016</xref>). We additionally quantified VGAT-positive inhibitory synapses around motoneuron cell bodies, as well as glutamatergic synapses, but the changes among those were not consistent and are difficult to explain in terms of possible connections with functional recovery (Jakovcevski et al., <xref ref-type="bibr" rid="B41">2007</xref>).</p>
<p>A further breakthrough was achieved while studying another adhesion molecule, extracellular matrix glycoprotein tenascin-C. Tenascin-C, as a part of the extracellular matrix, plays important roles in neural development and plasticity, but also wound healing (Jakovcevski et al., <xref ref-type="bibr" rid="B39">2013b</xref>). Tenascin-C−/− mice recover worse than their wild-type littermates after spinal cord injury, indicating a positive role that tenascin plays in regeneration (Chen et al., <xref ref-type="bibr" rid="B15">2010</xref>). In these animals we measured the Hoffman (H) reflex, as an electromyographic correlate of a monosynaptic tendon reflex, and a commonly taken measure of motoneuronal excitability in both humans and experimental animals (Knikou, <xref ref-type="bibr" rid="B43">2008</xref>), aimed to clarify the relationships between functional recovery, spinal reflex properties and spasticity after spinal cord injury (Lee et al., <xref ref-type="bibr" rid="B46">2009</xref>). Upon the electrical stimulation of the sciatic nerve, plantar muscle response is measured. The first response comes immediately, so-called M-wave, the product of direct stimulation of muscle though anterograde conduction of the spinal nerve. The stimulus is, however, also retrogradely conducted through Ia afferent to motoneuron and then back to the muscle. This, so-called “H” wave is a measure of motoneuron reflex integration. In the chronic phase of spinal cord injury, the H-reflex is facilitated upon single and repetitive low-frequency stimulation (Thompson et al., <xref ref-type="bibr" rid="B69">1992</xref>). As in the previous literature, we confirmed that, compared to the intact spinal cords, H-reflex is facilitated early (7 days) after injury, and remains high throughout the follow-up of 12 weeks (Lee et al., <xref ref-type="bibr" rid="B46">2009</xref>). Unexpectedly, however, the reflex moves closer to normal, lower values in TNC−/− mice, which recover worse, and remains higher in CHL1−/− mice, which recover better after injury (Lee et al., <xref ref-type="bibr" rid="B46">2009</xref>; Chen et al., <xref ref-type="bibr" rid="B15">2010</xref>). The same trend—higher H-reflex values compared to wild-type injured mice—was seen in tenascin-R−/− mice, another mouse model with facilitated functional recovery after injury (Lee et al., <xref ref-type="bibr" rid="B46">2009</xref>). These data indicated that spasticity after injury could play an important role in functional recovery during the subacute phase. We proceeded to assess glutamatergic, excitatory synapses in wild-type and tenascin-C−/− mice, to search for the possible structural correlates of the observed spasticity (Chen et al., <xref ref-type="bibr" rid="B15">2010</xref>). We analyzed glutamatergic input in three spinal cord areas in which VGLUT1-positive terminals were prominent: the Clarke’s column, which receives proprioceptive information from dorsal roots, an adjacent part of lamina VII, an area in the spinal cord containing last-order interneurons, i.e., innervating motoneurons, lamina IX, where proprio- and mechanoreceptors form contacts predominantly on motoneuron dendrites. Analysis of wild-type and tenascin-C−/− mice 12 weeks after injury revealed a significant, compared with non-injured mice, decline in the terminal densities in the Clarke’s column and lamina VII, and a strong increase in lamina IX in both genotypes. The conspicuously lower numbers of VGLUT1-positive terminals in lamina VII of tenascin-C−/− mice could lead to speculation that this is the structural correlate of lower H-reflex values in these mice (Chen et al., <xref ref-type="bibr" rid="B15">2010</xref>). The same method of analysis was applied to assess the role of polysialic acid (PSA) mimicking peptide in facilitating recovery upon spinal cord injury, and mice treated with PSA-mimic had higher numbers of VGLUT1-positive terminals in both laminae VII and IX compared with vehicle-treated animals (Mehanna et al., <xref ref-type="bibr" rid="B48">2010</xref>). This adds weight to the evidence that higher glutamatergic transmission in laminae VII and IX of injured spinal cords indicates better functional outcome.</p>
</sec>
<sec id="s6">
<title>Femoral Nerve Injury</title>
<p>Although the peripheral nervous system recovers from injury to a considerably higher degree than the central nervous system, injury to peripheral nerves still presents an important clinical problem, causing a significant degree of disability in patients (Navarro et al., <xref ref-type="bibr" rid="B51">2007</xref>; Irintchev, <xref ref-type="bibr" rid="B36">2011</xref>). The femoral nerve is a mixed nerve which divides into two terminal branches, a muscle branch to the quadriceps muscle and a cutaneous branch, the saphenous nerve. Injury immediately proximal to the bifurcation of the two branches affects a single muscle, the quadriceps. After surgical repair, the quadriceps motor axons have an equal opportunity to regrow into the original pathway, the quadriceps branch, or choose the wrong pathway, the purely sensory saphenous nerve (Akyüz et al., <xref ref-type="bibr" rid="B2">2013</xref>). This situation allows analyses of cellular and molecular mechanisms involved in specificity of motor reinnervation (Brushart, <xref ref-type="bibr" rid="B11">1993</xref>; Robinson and Madison, <xref ref-type="bibr" rid="B59">2005</xref>). In addition, the model is interesting because femoral nerve injury causes disability of a single muscle, the quadriceps, which functions as a knee extensor, thus allowing a simple approach for locomotor analysis (Irintchev, <xref ref-type="bibr" rid="B36">2011</xref>). The factors limiting recovery after nerve injury become even more complicated if we consider the complexity of central nervous system reorganization after peripheral nerve injury (Navarro et al., <xref ref-type="bibr" rid="B51">2007</xref>). To clarify some of this complexity, analysis of the synaptic remodeling after injury is essential. After nerve injury motoneurons are acutely deafferentiated and upon reinnervation of their target muscles they regain their synaptic afferents to varying degrees, as demonstrated by electron (Brännström and Kellerth, <xref ref-type="bibr" rid="B10">1999</xref>) and light microscopy (Hellstrom et al., <xref ref-type="bibr" rid="B31">2003</xref>).</p>
<p>Both cholinergic (ChAT-positive) and inhibitory (VGAT-positive) terminals around motoneuron cell bodies were studied by light microscopy in various mouse models of femoral nerve injury and surgical repair (Simova et al., <xref ref-type="bibr" rid="B65">2006</xref>; Guseva et al., <xref ref-type="bibr" rid="B28">2009</xref>, <xref ref-type="bibr" rid="B30">2011</xref>, <xref ref-type="bibr" rid="B29">2014</xref>; Mehanna et al., <xref ref-type="bibr" rid="B49">2014</xref>). Here, the linear density of perisomatic terminals immunoreactive for ChAT or VGAT was estimated around motoneurons retrogradely labeled at 3 months after injury. Retrograde labeling is important in this case, to take into account only injured motoneurons (i.e., those that give rise to the femoral nerve), and to avoid taking neurons which upon repair falsely projected through the sensory branch, and thus play no role in motor recovery (Akyüz et al., <xref ref-type="bibr" rid="B2">2013</xref>). Consideration must be given, however, that the retrograde labeling procedure involves a second surgery and nerve resection to apply the dye, which is typically conducted 1 week before sacrifice of the animals. Thus, the results of such analysis take into account data about simultaneous acute and chronic reaction of the nerve to injury. Both cholinergic and inhibitory perisomatic terminals were reduced in numbers 2 months after femoral nerve injury (Mehanna et al., <xref ref-type="bibr" rid="B49">2014</xref>), whereas at 3 months after injury only inhibitory terminals were reduced (Guseva et al., <xref ref-type="bibr" rid="B28">2009</xref>, <xref ref-type="bibr" rid="B30">2011</xref>), suggesting plasticity in the sub-acute and chronic phases of regeneration. To drive solid conclusions, however, about the central synaptic rearrangements after peripheral nerve injury further studies are necessary.</p>
</sec>
<sec id="s7">
<title>Conclusions and Outlook</title>
<p>We hope that by presenting several studies which combined functional and anatomical assessment, we add to the evidence that confocal synaptology is a reliable and convenient method to address various questions in neurobiology. Although there is no replacement for electron microscopy, as the standard method for visualization and morphological analysis of synapses, confocal synaptology presents itself as an excellent screening method, to assess the regions of interest and types of synapses to be analyzed by electron microscopy. As with all methods, it is of great importance to understand the limitations of this type of analysis. Although we have shown that in some cases, for particular types of synapses, the quantitative estimation achieved by this technique corresponds well with the functional parameters, the results should always be interpreted cautiously, and when possible attempted to correlate with the functional parameters. It should also be noted that the numerical values, in this case, are rather “synaptic score values” than the actual numbers of synapses, as synapses are precisely quantifiable only by electron microscopy. The advancement of super resolution fluorescence microscopy, however, will likely eventually blur the advantage of electron microscopy for the visualization of synapses (Dani and Huang, <xref ref-type="bibr" rid="B20">2010</xref>). Further studies are necessary to conclude in which cases the results of the light microscopic estimation of synaptic numbers and changes renders functionally relevant results, which will increase our understanding of the intricate circuitries of the central nervous system.</p>
</sec>
<sec id="s8">
<title>Author Contributions</title>
<p>MV, ND and IJ were involved in analyzing the literature and writing the manuscript.</p>
</sec>
<sec id="s9">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>The authors would like to thank Andrey Irintchev, for all the ideas and insights, Stephan L. Marguet for English editing, Dirk Isbrandt for critical reading, and Alan Peters for inspiring this manuscript.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahuja</surname><given-names>C. S.</given-names></name><name><surname>Wilson</surname><given-names>J. R.</given-names></name><name><surname>Nori</surname><given-names>S.</given-names></name><name><surname>Kotter</surname><given-names>M. R. N.</given-names></name><name><surname>Druschel</surname><given-names>C.</given-names></name><name><surname>Curt</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Traumatic spinal cord injury</article-title>. <source/>Nat. Rev. Dis. Primers
<volume>3</volume>:<fpage>17018</fpage>. <pub-id pub-id-type="doi">10.1038/nrdp.2017.18</pub-id><pub-id pub-id-type="pmid">28447605</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akyüz</surname><given-names>N.</given-names></name><name><surname>Rost</surname><given-names>S.</given-names></name><name><surname>Mehanna</surname><given-names>A.</given-names></name><name><surname>Bian</surname><given-names>S.</given-names></name><name><surname>Loers</surname><given-names>G.</given-names></name><name><surname>Oezen</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Dermatan4-O-sulfotransferase1 ablation accelerates peripheral nerve regeneration</article-title>. <source/>Exp. Neurol.
<volume>247</volume>, <fpage>517</fpage>–<lpage>530</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2013.01.025</pub-id><pub-id pub-id-type="pmid">23360803</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angeloni</surname><given-names>D.</given-names></name><name><surname>Lindor</surname><given-names>N. M.</given-names></name><name><surname>Pack</surname><given-names>S.</given-names></name><name><surname>Latif</surname><given-names>F.</given-names></name><name><surname>Wie</surname><given-names>M. H.</given-names></name><name><surname>Lerman</surname><given-names>M. I.</given-names></name></person-group> (<year>1999</year>). <article-title>CALL gene is haploinsufficient in a 3p- syndrome patient</article-title>. <source/>Am. J. Med. Genet.
<volume>86</volume>, <fpage>482</fpage>–<lpage>485</lpage>. <pub-id pub-id-type="doi">10.1002/(sici)1096-8628(19991029)86:5&lt;482::aid-ajmg15&gt;3.0.co;2-l</pub-id><pub-id pub-id-type="pmid">10508992</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Apostolova</surname><given-names>I.</given-names></name><name><surname>Irintchev</surname><given-names>A.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name></person-group> (<year>2006</year>). <article-title>Tenascin-R restricts posttraumatic remodeling of motoneuron innervation and functional recovery after spinal cord injury in adult mice</article-title>. <source/>J. Neurosci.
<volume>26</volume>, <fpage>7849</fpage>–<lpage>7859</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1526-06.2006</pub-id><pub-id pub-id-type="pmid">16870730</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arendt</surname><given-names>T.</given-names></name></person-group> (<year>2009</year>). <article-title>Synaptic degeneration in Alzheimer’s disease</article-title>. <source/>Acta Neuropathol.
<volume>118</volume>, <fpage>167</fpage>–<lpage>179</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-009-0536-x</pub-id><pub-id pub-id-type="pmid">19390859</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basso</surname><given-names>D. M.</given-names></name><name><surname>Fisher</surname><given-names>L. C.</given-names></name><name><surname>Anderson</surname><given-names>A. J.</given-names></name><name><surname>Jakeman</surname><given-names>L. B.</given-names></name><name><surname>McTigue</surname><given-names>D. M.</given-names></name><name><surname>Popovich</surname><given-names>P. G.</given-names></name></person-group> (<year>2006</year>). <article-title>Basso mouse scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains</article-title>. <source/>J. Neurotrauma
<volume>23</volume>, <fpage>635</fpage>–<lpage>659</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2006.23.635</pub-id><pub-id pub-id-type="pmid">16689667</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>K. P.</given-names></name><name><surname>Nedivi</surname><given-names>E.</given-names></name></person-group> (<year>2017</year>). <article-title>Spine dynamics: are they all the same?</article-title>
<source/>Neuron
<volume>96</volume>, <fpage>43</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2017.08.008</pub-id><pub-id pub-id-type="pmid">28957675</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bikoff</surname><given-names>J. B.</given-names></name><name><surname>Gabitto</surname><given-names>M. I.</given-names></name><name><surname>Rivard</surname><given-names>A. F.</given-names></name><name><surname>Drobac</surname><given-names>E.</given-names></name><name><surname>Machado</surname><given-names>T. A.</given-names></name><name><surname>Miri</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Spinal inhibitory interneuron diversity delineates variant motor microcircuits</article-title>. <source/>Cell
<volume>165</volume>, <fpage>207</fpage>–<lpage>219</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.01.027</pub-id><pub-id pub-id-type="pmid">26949184</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bliss</surname><given-names>T. V.</given-names></name><name><surname>Lomo</surname><given-names>T.</given-names></name></person-group> (<year>1973</year>). <article-title>Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path</article-title>. <source/>J. Physiol.
<volume>232</volume>, <fpage>331</fpage>–<lpage>356</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.1973.sp010273</pub-id><pub-id pub-id-type="pmid">4727084</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brännström</surname><given-names>T.</given-names></name><name><surname>Kellerth</surname><given-names>J. O.</given-names></name></person-group> (<year>1999</year>). <article-title>Recovery of synapses in axotomized adult cat spinal motoneurons after reinnervation into muscle</article-title>. <source/>Exp. Brain Res.
<volume>125</volume>, <fpage>19</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1007/s002210050653</pub-id><pub-id pub-id-type="pmid">10100972</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brushart</surname><given-names>T. M.</given-names></name></person-group> (<year>1993</year>). <article-title>Motor axons preferentially reinnervate motor pathways</article-title>. <source/>J. Neurosci.
<volume>13</volume>, <fpage>2730</fpage>–<lpage>2738</lpage>. <pub-id pub-id-type="pmid">8501535</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bullock</surname><given-names>T. H.</given-names></name><name><surname>Bennett</surname><given-names>M. V. L.</given-names></name><name><surname>Johnston</surname><given-names>D.</given-names></name><name><surname>Josephson</surname><given-names>R.</given-names></name><name><surname>Marder</surname><given-names>E.</given-names></name><name><surname>Fields</surname><given-names>R. D.</given-names></name></person-group> (<year>2005</year>). <article-title>The neuron doctrine, redux</article-title>. <source/>Science
<volume>310</volume>, <fpage>791</fpage>–<lpage>793</lpage>. <pub-id pub-id-type="doi">10.1126/science.1114394</pub-id><pub-id pub-id-type="pmid">16272104</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cajal</surname><given-names>S. R.</given-names></name></person-group> (<year>1911</year>). <source/>Histologie du Système Nerveux de l’Hommeet des Vertébrés.
<publisher-loc>Paris</publisher-loc>: <publisher-name>Maloine</publisher-name>.</mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cajal</surname><given-names>S. R. Y.</given-names></name></person-group> (<year>1928</year>). “<article-title>Study of traumatic degeneration in the cerebral cortex</article-title>,” in <source/>Degeneration and Regeneration of the Nervous System, ed. <person-group person-group-type="editor"><name><surname>May</surname><given-names>R. M.</given-names></name></person-group> (<publisher-loc>London</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>), <fpage>656</fpage>–<lpage>692</lpage>.</mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Q. Y.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>Feng</surname><given-names>G. Y.</given-names></name><name><surname>Lindpaintner</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Case-control association study of the close homologue of L1 (CHL1) gene and schizophrenia in the Chinese population</article-title>. <source/>Schizophr. Res.
<volume>73</volume>, <fpage>269</fpage>–<lpage>274</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2004.06.001</pub-id><pub-id pub-id-type="pmid">15653271</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Joon Lee</surname><given-names>H.</given-names></name><name><surname>Jakovcevski</surname><given-names>I.</given-names></name><name><surname>Shah</surname><given-names>R.</given-names></name><name><surname>Bhagat</surname><given-names>N.</given-names></name><name><surname>Loers</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>The extracellular matrix glycoprotein tenascin-C is beneficial for spinal cord regeneration</article-title>. <source/>Mol. Ther.
<volume>18</volume>, <fpage>1769</fpage>–<lpage>1777</lpage>. <pub-id pub-id-type="doi">10.1038/mt.2010.133</pub-id><pub-id pub-id-type="pmid">20606643</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Apostolova</surname><given-names>I.</given-names></name><name><surname>Skup</surname><given-names>M.</given-names></name><name><surname>Irintchev</surname><given-names>A.</given-names></name><name><surname>Kügler</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Adeno-associated virus-mediated L1 expression promotes functional recovery after spinal cord injury</article-title>. <source/>Brain
<volume>130</volume>, <fpage>954</fpage>–<lpage>969</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awm049</pub-id><pub-id pub-id-type="pmid">17438016</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>Y. F.</given-names></name><name><surname>Hargus</surname><given-names>G.</given-names></name><name><surname>Xu</surname><given-names>J. C.</given-names></name><name><surname>Schmid</surname><given-names>J. S.</given-names></name><name><surname>Shen</surname><given-names>Y. Q.</given-names></name><name><surname>Glatzel</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice</article-title>. <source/>Brain
<volume>133</volume>, <fpage>189</fpage>–<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awp290</pub-id><pub-id pub-id-type="pmid">19995872</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>Y. F.</given-names></name><name><surname>Xu</surname><given-names>J. C.</given-names></name><name><surname>Hargus</surname><given-names>G.</given-names></name><name><surname>Jakovcevski</surname><given-names>I.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name><name><surname>Bernreuther</surname><given-names>C.</given-names></name></person-group> (<year>2011</year>). <article-title>Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery after spinal cord injury in mice</article-title>. <source/>PLoS One
<volume>6</volume>:<fpage>e17126</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0017126</pub-id><pub-id pub-id-type="pmid">21445247</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dani</surname><given-names>A.</given-names></name><name><surname>Huang</surname><given-names>B.</given-names></name></person-group> (<year>2010</year>). <article-title>New resolving power for light microscopy: applications to neurobiology</article-title>. <source/>Curr. Opin. Neurobiol.
<volume>20</volume>, <fpage>648</fpage>–<lpage>652</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2010.07.006</pub-id><pub-id pub-id-type="pmid">20728340</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidoff</surname><given-names>M. S.</given-names></name><name><surname>Irintchev</surname><given-names>A. P.</given-names></name></person-group> (<year>1986</year>). <article-title>Acetylcholinesterase activity and type C synapses in the hypoglossal, facial and spinal-cord motor nuclei of rats. An electron-microscope study</article-title>. <source/>Histochemistry
<volume>84</volume>, <fpage>515</fpage>–<lpage>524</lpage>. <pub-id pub-id-type="doi">10.1007/bf00482985</pub-id><pub-id pub-id-type="pmid">3721918</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demyanenko</surname><given-names>G. P.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name><name><surname>Anton</surname><given-names>E.</given-names></name><name><surname>Schmid</surname><given-names>R.</given-names></name><name><surname>Feng</surname><given-names>G.</given-names></name><name><surname>Sanes</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Close homolog of L1 modulates area-specific neuronal positioning and dendrite orientation in the cerebral cortex</article-title>. <source/>Neuron
<volume>44</volume>, <fpage>423</fpage>–<lpage>437</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2004.10.016</pub-id><pub-id pub-id-type="pmid">15504324</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Djogo</surname><given-names>N.</given-names></name><name><surname>Jakovcevski</surname><given-names>I.</given-names></name><name><surname>Müller</surname><given-names>C.</given-names></name><name><surname>Lee</surname><given-names>H. J.</given-names></name><name><surname>Xu</surname><given-names>J. C.</given-names></name><name><surname>Jakovcevski</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Adhesion molecule L1 binds to amyloid β and reduces Alzheimer’s disease pathology in mice</article-title>. <source/>Neurobiol. Dis.
<volume>56</volume>, <fpage>104</fpage>–<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2013.04.014</pub-id><pub-id pub-id-type="pmid">23639788</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eccles</surname><given-names>J. C.</given-names></name><name><surname>Llinás</surname><given-names>R.</given-names></name><name><surname>Sasaki</surname><given-names>K.</given-names></name></person-group> (<year>1966</year>). <article-title>The excitatory synaptic action of climbing fibres on the Purkinje cells of the cerebellum</article-title>. <source/>J. Physiol.
<volume>182</volume>, <fpage>268</fpage>–<lpage>296</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.1966.sp007824</pub-id><pub-id pub-id-type="pmid">5944665</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fremeau</surname><given-names>R. T. J.</given-names></name><name><surname>Kam</surname><given-names>K.</given-names></name><name><surname>Qureshi</surname><given-names>T.</given-names></name><name><surname>Johnson</surname><given-names>J.</given-names></name><name><surname>Copenhagen</surname><given-names>D. R.</given-names></name><name><surname>Storm-Mathisen</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites</article-title>. <source/>Science
<volume>304</volume>, <fpage>1815</fpage>–<lpage>1819</lpage>. <pub-id pub-id-type="doi">10.1126/science.1097468</pub-id><pub-id pub-id-type="pmid">15118123</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujiyama</surname><given-names>F.</given-names></name><name><surname>Furuta</surname><given-names>T.</given-names></name><name><surname>Kaneko</surname><given-names>T.</given-names></name></person-group> (<year>2001</year>). <article-title>Immunocytochemical localization of candidates for vesicular glutamate transporters in the rat cerebral cortex</article-title>. <source/>J. Comp. Neurol.
<volume>435</volume>, <fpage>379</fpage>–<lpage>387</lpage>. <pub-id pub-id-type="doi">10.1002/cne.1037</pub-id><pub-id pub-id-type="pmid">11406819</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gulyás</surname><given-names>A. I.</given-names></name><name><surname>Megias</surname><given-names>M.</given-names></name><name><surname>Emri</surname><given-names>Z.</given-names></name><name><surname>Freund</surname><given-names>T. F.</given-names></name></person-group> (<year>1999</year>). <article-title>Total number and ratio of excitatory and inhibitory synapses converging onto single interneurons of different types in the CA1 area of the rat hippocampus</article-title>. <source/>J. Neurosci.
<volume>19</volume>, <fpage>10082</fpage>–<lpage>10097</lpage>. <pub-id pub-id-type="pmid">10559416</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guseva</surname><given-names>D.</given-names></name><name><surname>Angelov</surname><given-names>D. N.</given-names></name><name><surname>Irintchev</surname><given-names>A.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>Ablation of adhesion molecule L1 in mice favours Schwann cell proliferation and functional recovery after peripheral nerve injury</article-title>. <source/>Brain
<volume>132</volume>, <fpage>2180</fpage>–<lpage>2195</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awp160</pub-id><pub-id pub-id-type="pmid">19541848</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guseva</surname><given-names>D.</given-names></name><name><surname>Loers</surname><given-names>G.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Function-triggering antibodies to the adhesionmolecule L1 enhance recovery after injury of the adult mouse femoral nerve</article-title>. <source/>PLoS One
<volume>9</volume>:<fpage>e112984</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0112984</pub-id><pub-id pub-id-type="pmid">25393007</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guseva</surname><given-names>D.</given-names></name><name><surname>Zerwas</surname><given-names>M.</given-names></name><name><surname>Xiao</surname><given-names>M. F.</given-names></name><name><surname>Jakovcevski</surname><given-names>I.</given-names></name><name><surname>Irintchev</surname><given-names>A.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Adhesion molecule L1 overexpressed under the control of the neuronal Thy-1 promoter improves myelination after peripheral nerve injury in adult mice</article-title>. <source/>Exp. Neurol.
<volume>229</volume>, <fpage>339</fpage>–<lpage>352</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2011.02.018</pub-id><pub-id pub-id-type="pmid">21376041</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hellstrom</surname><given-names>J.</given-names></name><name><surname>Oliveira</surname><given-names>A. L.</given-names></name><name><surname>Meister</surname><given-names>B.</given-names></name><name><surname>Cullheim</surname><given-names>S.</given-names></name></person-group> (<year>2003</year>). <article-title>Large cholinergic nerve terminals on subsets of motoneurons and their relation to muscarinic receptor type 2</article-title>. <source/>J. Comp. Neurol.
<volume>460</volume>, <fpage>476</fpage>–<lpage>486</lpage>. <pub-id pub-id-type="doi">10.1002/cne.10648</pub-id><pub-id pub-id-type="pmid">12717708</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hisano</surname><given-names>S.</given-names></name><name><surname>Sawada</surname><given-names>K.</given-names></name><name><surname>Kawano</surname><given-names>M.</given-names></name><name><surname>Kanemoto</surname><given-names>M.</given-names></name><name><surname>Xiong</surname><given-names>G.</given-names></name><name><surname>Mogi</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Expression of inorganic phosphate/vesicular glutamate transporters (BNPI/VGLUT1 and DNPI/VGLUT2) in the cerebellum and precerebellar nuclei of the rat</article-title>. <source/>Brain. Res. Mol. Brain. Res.
<volume>107</volume>, <fpage>23</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/s0169-328x(02)00442-4</pub-id><pub-id pub-id-type="pmid">12414120</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Bates</surname><given-names>M.</given-names></name><name><surname>Zhuang</surname><given-names>X.</given-names></name></person-group> (<year>2008</year>). <article-title>Three-dimensional super-resolution imaging by stochastic optical reconstruction microscopy</article-title>. <source/>Science
<volume>319</volume>, <fpage>810</fpage>–<lpage>813</lpage>. <pub-id pub-id-type="doi">10.1126/science.1153529</pub-id><pub-id pub-id-type="pmid">18174397</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunt</surname><given-names>C. A.</given-names></name><name><surname>Schenker</surname><given-names>L. J.</given-names></name><name><surname>Kennedy</surname><given-names>M. B.</given-names></name></person-group> (<year>1996</year>). <article-title>PSD-95 is associated with the postsynaptic density and not with the presynaptic membrane at forebrain synapses</article-title>. <source/>J. Neurosci.
<volume>16</volume>, <fpage>1380</fpage>–<lpage>1388</lpage>. <pub-id pub-id-type="pmid">8778289</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irintchev</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Potentials and limitations of peripheral nerve injury models in rodents with particular reference to the femoral nerve</article-title>. <source/>Ann. Anat.
<volume>193</volume>, <fpage>276</fpage>–<lpage>285</lpage>. <pub-id pub-id-type="doi">10.1016/j.aanat.2011.02.019</pub-id><pub-id pub-id-type="pmid">21481575</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irintchev</surname><given-names>A.</given-names></name><name><surname>Koch</surname><given-names>M.</given-names></name><name><surname>Needham</surname><given-names>L.</given-names></name><name><surname>Maness</surname><given-names>P.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>Impairment of sensorimotor gating in mice deficient in the cell adhesion molecule L1 or its close homologue, CHL1</article-title>. <source/>Brain. Res
<volume>1029</volume>, <fpage>131</fpage>–<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2004.09.042</pub-id><pub-id pub-id-type="pmid">15533325</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irintchev</surname><given-names>A.</given-names></name><name><surname>Rollenhagen</surname><given-names>A.</given-names></name><name><surname>Troncoso</surname><given-names>E.</given-names></name><name><surname>Kiss</surname><given-names>J. Z.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name></person-group> (<year>2005</year>). <article-title>Structural and functional aberrations in the cerebral cortex of tenascin-C deficient mice</article-title>. <source/>Cereb. Cortex
<volume>15</volume>, <fpage>950</fpage>–<lpage>962</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhh195</pub-id><pub-id pub-id-type="pmid">15537675</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakovcevski</surname><given-names>I.</given-names></name><name><surname>Djogo</surname><given-names>N.</given-names></name><name><surname>Hölters</surname><given-names>L. S.</given-names></name><name><surname>Szpotowicz</surname><given-names>E.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name></person-group> (<year>2013a</year>). <article-title>Transgenic overexpression of the cell adhesion molecule L1 in neurons facilitates recovery after mouse spinal cord injury</article-title>. <source/>Neuroscience
<volume>252</volume>, <fpage>1</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2013.07.067</pub-id><pub-id pub-id-type="pmid">23933311</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakovcevski</surname><given-names>I.</given-names></name><name><surname>Miljkovic</surname><given-names>D.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name><name><surname>Andjus</surname><given-names>P. R.</given-names></name></person-group> (<year>2013b</year>). <article-title>Tenascins and inflammation in disorders of the nervous system</article-title>. <source/>Amino Acids
<volume>44</volume>, <fpage>1115</fpage>–<lpage>1127</lpage>. <pub-id pub-id-type="doi">10.1007/s00726-012-1446-0</pub-id><pub-id pub-id-type="pmid">23269478</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakovcevski</surname><given-names>I.</given-names></name><name><surname>Siering</surname><given-names>J.</given-names></name><name><surname>Hargus</surname><given-names>G.</given-names></name><name><surname>Karl</surname><given-names>N.</given-names></name><name><surname>Hoelters</surname><given-names>L.</given-names></name><name><surname>Djogo</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Close homologue of adhesion molecule L1 promotes survival of Purkinje and granule cells and granule cell migration during murine cerebellar development</article-title>. <source/>J. Comp. Neurol.
<volume>513</volume>, <fpage>496</fpage>–<lpage>510</lpage>. <pub-id pub-id-type="doi">10.1002/cne.21981</pub-id><pub-id pub-id-type="pmid">19226508</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakovcevski</surname><given-names>I.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Karl</surname><given-names>N.</given-names></name><name><surname>Leshchyns’ka</surname><given-names>I.</given-names></name><name><surname>Sytnyk</surname><given-names>V.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Glial scar expression of CHL1, the close homolog of the adhesion molecule L1, limits recovery after spinal cord injury</article-title>. <source/>J. Neurosci.
<volume>27</volume>, <fpage>7222</fpage>–<lpage>7233</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.0739-07.2007</pub-id><pub-id pub-id-type="pmid">17611275</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janz</surname><given-names>P.</given-names></name><name><surname>Savanthrapadian</surname><given-names>S.</given-names></name><name><surname>Häussler</surname><given-names>U.</given-names></name><name><surname>Kilias</surname><given-names>A.</given-names></name><name><surname>Nestel</surname><given-names>S.</given-names></name><name><surname>Kretz</surname><given-names>O.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Synaptic remodeling of entorhinal input contributes to an aberrant hippocampal network in temporal lobe epilepsy</article-title>. <source/>Cereb. Cortex
<volume>27</volume>, <fpage>2348</fpage>–<lpage>2364</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhw093</pub-id><pub-id pub-id-type="pmid">27073230</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katic</surname><given-names>J.</given-names></name><name><surname>Loers</surname><given-names>G.</given-names></name><name><surname>Kleene</surname><given-names>R.</given-names></name><name><surname>Karl</surname><given-names>N.</given-names></name><name><surname>Schmidt</surname><given-names>C.</given-names></name><name><surname>Buck</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Interaction of the cell adhesion molecule CHL1 with vitronectin, integrins and the plasminogen activator inhibitor-2 promotes CHL1-induced neurite outgrowth and neuronal migration</article-title>. <source/>J. Neurosci.
<volume>34</volume>, <fpage>14606</fpage>–<lpage>14623</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.3280-13.2014</pub-id><pub-id pub-id-type="pmid">25355214</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knikou</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>The H-reflex as a probe: pathways and pitfalls</article-title>. <source/>J. Neurosci. Methods
<volume>171</volume>, <fpage>1</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneumeth.2008.02.012</pub-id><pub-id pub-id-type="pmid">18394711</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolata</surname><given-names>S.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Light</surname><given-names>K.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name><name><surname>Matzel</surname><given-names>L. D.</given-names></name></person-group> (<year>2008</year>). <article-title>Impaired working memory duration but normal learning abilities found in mice that are conditionally deficient in the close homolog of L1</article-title>. <source/>J. Neurosci.
<volume>28</volume>, <fpage>13505</fpage>–<lpage>13510</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.2127-08.2008</pub-id><pub-id pub-id-type="pmid">19074023</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>H. J.</given-names></name><name><surname>Bian</surname><given-names>S.</given-names></name><name><surname>Jakovcevski</surname><given-names>I.</given-names></name><name><surname>Wu</surname><given-names>B.</given-names></name><name><surname>Irintchev</surname><given-names>A.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>Delayed applications of L1 and chondroitinase ABC promote recovery after spinal cord injury</article-title>. <source/>J. Neurotrauma
<volume>29</volume>, <fpage>1850</fpage>–<lpage>1863</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2011.2290</pub-id><pub-id pub-id-type="pmid">22497349</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>H. J.</given-names></name><name><surname>Jakovcevski</surname><given-names>I.</given-names></name><name><surname>Radonjic</surname><given-names>N.</given-names></name><name><surname>Hoelters</surname><given-names>L.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name><name><surname>Irintchev</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>Better functional outcome of compression spinal cord injury in mice is associated with enhanced H-reflex responses</article-title>. <source/>Exp. Neurol.
<volume>216</volume>, <fpage>365</fpage>–<lpage>374</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2008.12.009</pub-id><pub-id pub-id-type="pmid">19150614</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liguz-Lecznar</surname><given-names>M.</given-names></name><name><surname>Skangiel-Kramska</surname><given-names>J.</given-names></name></person-group> (<year>2007</year>). <article-title>Vesicular glutamate transporters (VGLUTs): the three musketeers of the glutamatergic system</article-title>. <source/>Acta Neurobiol. Exp.
<volume>67</volume>, <fpage>207</fpage>–<lpage>218</lpage>. Available online at: <ext-link ext-link-type="uri" xlink:href="https://ane.pl/archive?vol=67&amp;no=3&amp;id=6723">https://ane.pl/archive?vol=67&amp;no=3&amp;id=6723</ext-link><pub-id pub-id-type="pmid">17957901</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehanna</surname><given-names>A.</given-names></name><name><surname>Jakovcevski</surname><given-names>I.</given-names></name><name><surname>Acar</surname><given-names>A.</given-names></name><name><surname>Xiao</surname><given-names>M.</given-names></name><name><surname>Loers</surname><given-names>G.</given-names></name><name><surname>Rougon</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Polysialic acid glycomimetic promotes functional recovery and plasticity after spinal cord injury in mice</article-title>. <source/>Mol. Ther.
<volume>18</volume>, <fpage>34</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1038/mt.2009.235</pub-id><pub-id pub-id-type="pmid">19826404</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehanna</surname><given-names>A.</given-names></name><name><surname>Szpotowicz</surname><given-names>E.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name><name><surname>Jakovcevski</surname><given-names>I.</given-names></name></person-group> (<year>2014</year>). <article-title>Improved regeneration after femoral nerve injury in mice lacking functional T- and B-lymphocytes</article-title>. <source/>Exp. Neurol.
<volume>261</volume>, <fpage>147</fpage>–<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2014.06.012</pub-id><pub-id pub-id-type="pmid">24967682</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miles</surname><given-names>G. B.</given-names></name><name><surname>Hartley</surname><given-names>R.</given-names></name><name><surname>Todd</surname><given-names>A. J.</given-names></name><name><surname>Brownstone</surname><given-names>R. M.</given-names></name></person-group> (<year>2007</year>). <article-title>Spinal cholinergic interneurons regulate the excitability of motoneurons during locomotion</article-title>. <source/>Proc. Natl. Ac. Sci. U S A
<volume>104</volume>, <fpage>2448</fpage>–<lpage>2453</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0611134104</pub-id><pub-id pub-id-type="pmid">17287343</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarro</surname><given-names>X.</given-names></name><name><surname>Vivó</surname><given-names>M.</given-names></name><name><surname>Valero-Cabré</surname><given-names>A.</given-names></name></person-group> (<year>2007</year>). <article-title>Neural plasticity after peripheral nerve injury and regeneration</article-title>. <source/>Prog. Neurobiol.
<volume>82</volume>, <fpage>163</fpage>–<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2007.06.005</pub-id><pub-id pub-id-type="pmid">17643733</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicoll</surname><given-names>R. A.</given-names></name></person-group> (<year>2017</year>). <article-title>A brief history of long-term potentiation</article-title>. <source/>Neuron
<volume>93</volume>, <fpage>281</fpage>–<lpage>290</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2016.12.015</pub-id><pub-id pub-id-type="pmid">28103477</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikonenko</surname><given-names>A. G.</given-names></name><name><surname>Sun</surname><given-names>M.</given-names></name><name><surname>Lepsveridze</surname><given-names>E.</given-names></name><name><surname>Apostolova</surname><given-names>I.</given-names></name><name><surname>Petrova</surname><given-names>I.</given-names></name><name><surname>Irintchev</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Enhanced perisomatic inhibition and impaired long-term potentiation in the CA1 region of juvenile CHL1-deficient mice</article-title>. <source/>Eur. J. Neurosci.
<volume>23</volume>, <fpage>1839</fpage>–<lpage>1852</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2006.04710.x</pub-id><pub-id pub-id-type="pmid">16623841</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papastefanaki</surname><given-names>F.</given-names></name><name><surname>Jakovcevski</surname><given-names>I.</given-names></name><name><surname>Poulia</surname><given-names>N.</given-names></name><name><surname>Djogo</surname><given-names>N.</given-names></name><name><surname>Schulz</surname><given-names>F.</given-names></name><name><surname>Martinovic</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Intraspinal delivery of polyethylene glycol-coated gold nanoparticles promotes functional recovery after spinal cord injury</article-title>. <source/>Mol. Ther.
<volume>23</volume>, <fpage>993</fpage>–<lpage>1002</lpage>. <pub-id pub-id-type="doi">10.1038/mt.2015.50</pub-id><pub-id pub-id-type="pmid">25807288</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>A.</given-names></name></person-group> (<year>2002</year>). <article-title>Examining neocortical circuits: some background and facts</article-title>. <source/>J. Neurocytol.
<volume>31</volume>, <fpage>183</fpage>–<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1023/A:1024157522651</pub-id><pub-id pub-id-type="pmid">12815238</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Querfurth</surname><given-names>H. W.</given-names></name><name><surname>LaFerla</surname><given-names>F. M.</given-names></name></person-group> (<year>2010</year>). <article-title>Alzheimer’s disease</article-title>. <source/>N. Engl. J. Med.
<volume>362</volume>, <fpage>329</fpage>–<lpage>344</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra0909142</pub-id><pub-id pub-id-type="pmid">20107219</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radde</surname><given-names>R.</given-names></name><name><surname>Bolmont</surname><given-names>T.</given-names></name><name><surname>Kaeser</surname><given-names>S. A.</given-names></name><name><surname>Coomaraswamy</surname><given-names>J.</given-names></name><name><surname>Lindau</surname><given-names>D.</given-names></name><name><surname>Stolze</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Aβ42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology</article-title>. <source/>EMBO Rep.
<volume>7</volume>, <fpage>940</fpage>–<lpage>946</lpage>. <pub-id pub-id-type="doi">10.1038/sj.embor.7400784</pub-id><pub-id pub-id-type="pmid">16906128</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radonjić</surname><given-names>N. V.</given-names></name><name><surname>Jakovcevski</surname><given-names>I.</given-names></name><name><surname>Bumbaširević</surname><given-names>V.</given-names></name><name><surname>Petronijević</surname><given-names>N. D.</given-names></name></person-group> (<year>2013</year>). <article-title>Perinatal phencyclidine administration decreases the density of cortical interneurons and increases the expression of neuregulin-1</article-title>. <source/>Psychopharmacology
<volume>227</volume>, <fpage>673</fpage>–<lpage>683</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-013-2999-7</pub-id><pub-id pub-id-type="pmid">23380917</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>G. A.</given-names></name><name><surname>Madison</surname><given-names>R. D.</given-names></name></person-group> (<year>2005</year>). <article-title>Manipulations of the mouse femoral nerve influence the accuracy of pathway reinnervation by motor neurons</article-title>. <source/>Exp. Neurol.
<volume>192</volume>, <fpage>39</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2004.10.013</pub-id><pub-id pub-id-type="pmid">15698617</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rost</surname><given-names>S.</given-names></name><name><surname>Akyüz</surname><given-names>N.</given-names></name><name><surname>Martinovic</surname><given-names>T.</given-names></name><name><surname>Huckhagel</surname><given-names>T.</given-names></name><name><surname>Jakovcevski</surname><given-names>I.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Germline ablation of dermatan-4O-sulfotransferase1 reduces regeneration after mouse spinal cord injury</article-title>. <source/>Neuroscience
<volume>312</volume>, <fpage>74</fpage>–<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.11.013</pub-id><pub-id pub-id-type="pmid">26586562</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saini</surname><given-names>V.</given-names></name><name><surname>Loers</surname><given-names>G.</given-names></name><name><surname>Kaur</surname><given-names>G.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name><name><surname>Jakovcevski</surname><given-names>I.</given-names></name></person-group> (<year>2016</year>). <article-title>Impact of neural cell adhesion molecule deletion on regeneration after mouse spinal cord injury</article-title>. <source/>Eur. J. Neurosci.
<volume>44</volume>, <fpage>1734</fpage>–<lpage>1746</lpage>. <pub-id pub-id-type="doi">10.1111/ejn.13271</pub-id><pub-id pub-id-type="pmid">27178448</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sassoè-Pognetto</surname><given-names>M.</given-names></name><name><surname>Fritschy</surname><given-names>J. M.</given-names></name></person-group> (<year>2000</year>). <article-title>Mini-review: gephyrin, a major postsynaptic protein of GABAergic synapses</article-title>. <source/>Eur. J. Neurosci.
<volume>12</volume>, <fpage>2205</fpage>–<lpage>2210</lpage>. <pub-id pub-id-type="doi">10.1046/j.1460-9568.2000.00106.x</pub-id><pub-id pub-id-type="pmid">10947798</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schäfer</surname><given-names>M. K.</given-names></name><name><surname>Eiden</surname><given-names>L. E.</given-names></name><name><surname>Weihe</surname><given-names>E.</given-names></name></person-group> (<year>1998</year>). <article-title>Cholinergic neurons and terminal fields revealed by immunohistochemistry for the vesicular acetylcholine transporter. I. Central nervous system</article-title>. <source/>Neuroscience
<volume>84</volume>, <fpage>331</fpage>–<lpage>359</lpage>. <pub-id pub-id-type="doi">10.1016/s0306-4522(97)00516-2</pub-id><pub-id pub-id-type="pmid">9539209</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmalbach</surname><given-names>B.</given-names></name><name><surname>Lepsveridze</surname><given-names>E.</given-names></name><name><surname>Djogo</surname><given-names>N.</given-names></name><name><surname>Papashvili</surname><given-names>G.</given-names></name><name><surname>Kuang</surname><given-names>F.</given-names></name><name><surname>Leshchyns’ka</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Age-dependent loss of parvalbumin-expressing hippocampal interneurons in mice deficient in CHL1, a mental retardation and schizophrenia susceptibility gene</article-title>. <source/>J. Neurochem.
<volume>135</volume>, <fpage>830</fpage>–<lpage>844</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.13284</pub-id><pub-id pub-id-type="pmid">26285062</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simova</surname><given-names>O.</given-names></name><name><surname>Irintchev</surname><given-names>A.</given-names></name><name><surname>Mehanna</surname><given-names>A.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Dihné</surname><given-names>M.</given-names></name><name><surname>Bächle</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Carbohydrate mimics promote functional recovery after peripheral nerve repair</article-title>. <source/>Ann. Neurol.
<volume>60</volume>, <fpage>430</fpage>–<lpage>437</lpage>. <pub-id pub-id-type="doi">10.1002/ana.20948</pub-id><pub-id pub-id-type="pmid">16958115</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Südhof</surname><given-names>T. C.</given-names></name><name><surname>Malenka</surname><given-names>R. C.</given-names></name></person-group> (<year>2008</year>). <article-title>Understanding synapses: past, present and future</article-title>. <source/>Neuron
<volume>60</volume>, <fpage>469</fpage>–<lpage>476</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2008.10.011</pub-id><pub-id pub-id-type="pmid">18995821</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takamori</surname><given-names>S.</given-names></name><name><surname>Riedel</surname><given-names>D.</given-names></name><name><surname>Jahn</surname><given-names>R.</given-names></name></person-group> (<year>2000</year>). <article-title>Immunoisolation of GABA-specific synaptic vesicles defines a functionally distinct subset of synaptic vesicles</article-title>. <source/>J. Neurosci.
<volume>20</volume>, <fpage>4904</fpage>–<lpage>4911</lpage>. <pub-id pub-id-type="pmid">10864948</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terry</surname><given-names>R. D.</given-names></name><name><surname>Masliah</surname><given-names>E.</given-names></name><name><surname>Salmon</surname><given-names>D. P.</given-names></name><name><surname>Butters</surname><given-names>N.</given-names></name><name><surname>DeTeresa</surname><given-names>R.</given-names></name><name><surname>Hill</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>1991</year>). <article-title>Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment</article-title>. <source/>Ann. Neurol.
<volume>30</volume>, <fpage>572</fpage>–<lpage>580</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410300410</pub-id><pub-id pub-id-type="pmid">1789684</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>F. J.</given-names></name><name><surname>Reier</surname><given-names>P. J.</given-names></name><name><surname>Lucas</surname><given-names>C. C.</given-names></name><name><surname>Parmer</surname><given-names>R.</given-names></name></person-group> (<year>1992</year>). <article-title>Altered patterns of reflex excitability subsequent to contusion injury of the rat spinal cord</article-title>. <source/>J. Neurophysiol.
<volume>68</volume>, <fpage>1473</fpage>–<lpage>1486</lpage>. <pub-id pub-id-type="doi">10.1152/jn.1992.68.5.1473</pub-id><pub-id pub-id-type="pmid">1479425</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>A. G.</given-names></name><name><surname>Demyanenko</surname><given-names>G. P.</given-names></name><name><surname>Powell</surname><given-names>A.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name><name><surname>Enriquez-Barreto</surname><given-names>L.</given-names></name><name><surname>Tran</surname><given-names>T. S.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Close homolog of L1 and neuropilin 1 mediate guidance of thalamocortical axons at the ventral telencephalon</article-title>. <source/>J. Neurosci.
<volume>27</volume>, <fpage>13667</fpage>–<lpage>13679</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.2888-07.2007</pub-id><pub-id pub-id-type="pmid">18077678</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>B.</given-names></name><name><surname>Matic</surname><given-names>D.</given-names></name><name><surname>Djogo</surname><given-names>N.</given-names></name><name><surname>Szpotowicz</surname><given-names>E.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name><name><surname>Jakovcevski</surname><given-names>I.</given-names></name></person-group> (<year>2012</year>). <article-title>Improved regeneration after spinal cord injury in mice lacking functional T- and B-lymphocytes</article-title>. <source/>Exp. Neurol.
<volume>237</volume>, <fpage>274</fpage>–<lpage>285</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2012.07.016</pub-id><pub-id pub-id-type="pmid">22868200</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J. C.</given-names></name><name><surname>Bernreuther</surname><given-names>C.</given-names></name><name><surname>Cui</surname><given-names>Y. F.</given-names></name><name><surname>Jakovcevski</surname><given-names>I.</given-names></name><name><surname>Hargus</surname><given-names>G.</given-names></name><name><surname>Xiao</surname><given-names>M. F.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Transplanted L1 expressing radial glia and astrocytes enhance recovery after spinal cord injury</article-title>. <source/>J. Neurotrauma
<volume>28</volume>, <fpage>1921</fpage>–<lpage>1937</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2011.1783</pub-id><pub-id pub-id-type="pmid">21671795</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zagoraiou</surname><given-names>L.</given-names></name><name><surname>Akay</surname><given-names>T.</given-names></name><name><surname>Martin</surname><given-names>J. F.</given-names></name><name><surname>Brownstone</surname><given-names>R. M.</given-names></name><name><surname>Jessell</surname><given-names>T. M.</given-names></name><name><surname>Miles</surname><given-names>G. B.</given-names></name></person-group> (<year>2009</year>). <article-title>A cluster of cholinergic premotor interneurons modulates mouse locomotor activity</article-title>. <source/>Neuron
<volume>64</volume>, <fpage>645</fpage>–<lpage>662</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2009.10.017</pub-id><pub-id pub-id-type="pmid">20005822</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>